We are live on ! Find out more
ACA

Arena Capital Advisors Portfolio holdings

AUM $208M
1-Year Est. Return 11.42%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+11.42%
3 Year Est. Return
+124.07%
5 Year Est. Return
+150.35%
10 Year Est. Return
AUM
$329M
AUM Growth
-$66.5M
Cap. Flow
-$67.7M
Cap. Flow %
-20.57%
Top 10 Hldgs %
37.47%
Holding
288
New
6
Increased
3
Reduced
84
Closed
31

Sector Composition

Rank Sector Weight
1 Financials 90.58%
2 Industrials 2.54%
3 Healthcare 2.32%
4 Materials 1.5%
5 Technology 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDOT
51
DELISTED
Peridot Acquisition Corp. II
PDOT
$2.2M 0.67%
221,492
+200,000
+931% +$1.97M
SKYA
52
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
$2.19M 0.67%
222,731
FTCV
53
DELISTED
FinTech Acquisition Corp. V Class A Common Stock
FTCV
$2.18M 0.66%
219,063
SVFB
54
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
$1.91M 0.58%
191,797
OSTR
55
DELISTED
Oyster Enterprises Acquisition Corp. Class A Common Stock
OSTR
$1.9M 0.58%
191,777
SDAC
56
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
$1.83M 0.55%
185,152
-200,000
-52% -$1.97M
SLAC
57
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
$1.8M 0.55%
183,364
BLTS
58
DELISTED
Bright Lights Acquisition Corp. Class A Common Stock
BLTS
$1.76M 0.53%
177,220
IRAA
59
DELISTED
Iris Acquisition Corp Class A Common Stock
IRAA
$1.71M 0.52%
174,233
ZING
60
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
$1.61M 0.49%
160,000
PRDS
61
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$1.57M 0.48%
851,281
NPAB
62
DELISTED
New Providence Acquisition Corp. II Class A Common Stock
NPAB
$1.54M 0.47%
153,249
ORIA
63
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$1.39M 0.42%
141,317
-109,600
-44% -$1.08M
DNAB
64
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$1.36M 0.41%
139,175
JWSM
65
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$1.33M 0.4%
133,887
APMI
66
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
$1.2M 0.37%
124,020
DNAD
67
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$1.13M 0.34%
114,972
FACA
68
DELISTED
Figure Acquisition Corp. I
FACA
$1.08M 0.33%
110,027
CLIM
69
DELISTED
Climate Real Impact Solutions II Acquisition Corporation
CLIM
$1.01M 0.31%
102,772
CLAA
70
DELISTED
Colonnade Acquisition Corp. II
CLAA
$992K 0.3%
+100,000
New +$986K
HIGA
71
DELISTED
H.I.G. Acquisition Corp.
HIGA
$889K 0.27%
88,678
JUGG
72
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
$865K 0.26%
87,971
PL icon
73
Planet Labs
PL
$8.53B
$839K 0.25%
154,431
-408,447
-73% -$2.26M
LICY
74
DELISTED
Li-Cycle Holdings Corp.
LICY
$798K 0.24%
18,750
GFGD
75
DELISTED
The Growth for Good Acquisition Corporation Class A Ordinary Shares
GFGD
$790K 0.24%
80,000

Similar funds

Arena Capital Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Arena Capital Advisors held 288 positions worth $329M, down 17% from $396M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arena Capital Advisors withdrew a net $67.7M in Q3 2022, closing 31 positions and reducing 84 holdings. Its most notable exit was ProKidney, an estimated $11.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 91% of assets, up from 82% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Arena Capital Advisors opened a new position in Vector Acquisition Corporation II Class A Ordinary Shares worth $2.97M.

  • Arena Capital Advisors's largest Q3 2022 buy was Vector Acquisition Corporation II Class A Ordinary Shares: 300,000 shares worth $2.97M.
  • Arena Capital Advisors added most to VectoIQ Acquisition Corp. II Class A Common Stock in Q3 2022, an estimated $3.89M increase.
  • Arena Capital Advisors's biggest Q3 2022 reduction was G Squared Ascend I Inc., cutting an estimated $2.97M.
  • Arena Capital Advisors fully exited ProKidney in Q3 2022, selling an estimated $11.7M.
  • Arena Capital Advisors's ten largest holdings make up 37% of its $329M portfolio in Q3 2022.
  • Arena Capital Advisors opened 6 new positions and closed 31 in Q3 2022.
  • Arena Capital Advisors's portfolio value fell 17% quarter-over-quarter to $329M.

Based on Arena Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.